These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 3975254)
21. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats. Schmassmann A; Peskar BM; Stettler C; Netzer P; Stroff T; Flogerzi B; Halter F Br J Pharmacol; 1998 Mar; 123(5):795-804. PubMed ID: 9535006 [TBL] [Abstract][Full Text] [Related]
22. Role of food in gastrointestinal ulceration produced by indomethacin in the rat. Satoh H; Guth PH; Grossman MI Gastroenterology; 1982 Jul; 83(1 Pt 2):210-5. PubMed ID: 7084604 [TBL] [Abstract][Full Text] [Related]
23. Gastrointestinal cytoprotection by indomethacin + sodium salicylate combination in rat. Ezer E; Matuz J; Pallagi K; Szporny L Acta Physiol Hung; 1984; 64(3-4):355-9. PubMed ID: 6532123 [TBL] [Abstract][Full Text] [Related]
24. Gastroparesis Worsens Indomethacin-Induced Gastric Antral Ulcers by Bile Reflux via Activation of 5-HT Satoh H; Akiba Y; Urushidani T; Kaunitz JD Dig Dis Sci; 2023 Oct; 68(10):3886-3901. PubMed ID: 37632663 [TBL] [Abstract][Full Text] [Related]
25. Comparative studies on the amino acid derivatives of indometacin. Krupińska J; Mazur J; Piotrowicz J; Cebo B; Stephanus R Pol J Pharmacol Pharm; 1986; 38(2):149-56. PubMed ID: 3092202 [TBL] [Abstract][Full Text] [Related]
26. Ulcerogenicity and effect on inhibition of prostaglandin generation of indometacin farnesil, a prodrug of indomethacin, in rat gastric mucosa: comparison with indomethacin or loxoprofen. Arakawa T; Fukuda T; Nakagawa K; Higuchi K; Watanabe T; Tominaga K; Kobayashi K Drugs Exp Clin Res; 1995; 21(3):85-8. PubMed ID: 7555616 [TBL] [Abstract][Full Text] [Related]
27. Preventive effect of atropine on indomethacin-induced gastrointestinal mucosal and vascular damage in rats. Karádi O; Abdel-Salam OM; Bódis B; Mózsik G Pharmacology; 1996 Jan; 52(1):46-55. PubMed ID: 8966202 [TBL] [Abstract][Full Text] [Related]
28. Protective action of SCH 12223 against experimentally induced gastric and intestinal lesions. Chiu PJ; Barnett A; Siegel M; Brown AD; Gerhart C J Pharmacol Exp Ther; 1988 Aug; 246(2):578-84. PubMed ID: 3404447 [TBL] [Abstract][Full Text] [Related]
29. Oral glutamine attenuates indomethacin-induced small intestinal damage. Basivireddy J; Jacob M; Balasubramanian KA Clin Sci (Lond); 2004 Sep; 107(3):281-9. PubMed ID: 15128285 [TBL] [Abstract][Full Text] [Related]
30. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease. Rainsford KD; Stetsko PI; Sirko SP; Debski S J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509 [TBL] [Abstract][Full Text] [Related]
31. [Cell kinetic study on the healing process of indomethacin-induced gastric mucosal lesion of rats]. Ohtsu K; Fukumoto S; Shimada Y Nihon Shokakibyo Gakkai Zasshi; 1991 Jan; 88(1):3-11. PubMed ID: 2027249 [TBL] [Abstract][Full Text] [Related]
32. The healing of NSAID-induced gastric lesion may be followed by small intestinal and cardiovascular side effects. Filaretova LP; Bagaeva TR; Morozova OY; Zelena D J Physiol Pharmacol; 2011 Dec; 62(6):619-25. PubMed ID: 22314564 [TBL] [Abstract][Full Text] [Related]
33. Centella asiatica Leaf Extract Protects Against Indomethacin-Induced Gastric Mucosal Injury in Rats. Zheng HM; Choi MJ; Kim JM; Cha KH; Lee KW; Park YH; Hong SS; Lee DH J Med Food; 2016 Jan; 19(1):38-46. PubMed ID: 26469560 [TBL] [Abstract][Full Text] [Related]
34. The effect of gastric cytoprotective drugs (atropine, cimetidine, vitamin-A) on the indomethacin induced intestinal ulcers in rats. Beró T; Németh A; Mózsik G; Jávor T Acta Physiol Hung; 1984; 64(3-4):343-7. PubMed ID: 6532122 [TBL] [Abstract][Full Text] [Related]
35. Morphine potentiates the gastroulcerogenic effect of indometacin in rats. Gyires K; Fürst S; Farczádi E; Márton A Pharmacology; 1985; 30(1):25-31. PubMed ID: 3975253 [TBL] [Abstract][Full Text] [Related]
36. Resistance of germfree rats to indomethacin-induced intestinal lesions. Robert A; Asano T Prostaglandins; 1977 Aug; 14(2):333-41. PubMed ID: 331401 [TBL] [Abstract][Full Text] [Related]
37. Protective effect of pranlukast, a cysteinyl-leukotriene receptor 1 antagonist, on indomethacin-induced small intestinal damage in rats. Nishio H; Hayashi Y; Terashima S; Takeuchi K Inflammopharmacology; 2007 Dec; 15(6):266-72. PubMed ID: 18236018 [TBL] [Abstract][Full Text] [Related]
38. Mucosal protective agents prevent exacerbation of NSAID-induced small intestinal lesions caused by antisecretory drugs in rats. Satoh H; Amagase K; Takeuchi K J Pharmacol Exp Ther; 2014 Feb; 348(2):227-35. PubMed ID: 24254524 [TBL] [Abstract][Full Text] [Related]
39. The inhibition of gastric mucosal lesion, oxidative stress and neutrophil-infiltration in rats by the lichen constituent diffractaic acid. Bayir Y; Odabasoglu F; Cakir A; Aslan A; Suleyman H; Halici M; Kazaz C Phytomedicine; 2006 Sep; 13(8):584-90. PubMed ID: 16920514 [TBL] [Abstract][Full Text] [Related]
40. The gastric fundic mucosal energy systems and the HCl-induced lesions in rats in dependence on starvation. Morón F; Nagy L; Mózsik G Acta Med Hung; 1984; 41(4):253-8. PubMed ID: 6096801 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]